These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 27250673)
41. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules. Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153 [TBL] [Abstract][Full Text] [Related]
42. In Vitro Evaluation of a Novel mRNA-Based Therapeutic Strategy for the Treatment of Patients Suffering from Alpha-1-Antitrypsin Deficiency. Michel T; Kankura A; Salinas Medina ML; Kurz J; Behring A; Avci-Adali M; Nolte A; Schlensak C; Wendel HP; Krajewski S Nucleic Acid Ther; 2015 Oct; 25(5):235-44. PubMed ID: 26125662 [TBL] [Abstract][Full Text] [Related]
43. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger. Devoldere J; Dewitte H; De Smedt SC; Remaut K Drug Discov Today; 2016 Jan; 21(1):11-25. PubMed ID: 26210957 [TBL] [Abstract][Full Text] [Related]
44. Cellular reprogramming by transcription factor engineering. Tsang JC; Gao X; Lu L; Liu P Curr Opin Genet Dev; 2014 Oct; 28():1-9. PubMed ID: 25151337 [TBL] [Abstract][Full Text] [Related]
45. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs. Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169 [TBL] [Abstract][Full Text] [Related]
46. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA. Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578 [TBL] [Abstract][Full Text] [Related]
47. Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap Henderson JM; Ujita A; Hill E; Yousif-Rosales S; Smith C; Ko N; McReynolds T; Cabral CR; Escamilla-Powers JR; Houston ME Curr Protoc; 2021 Feb; 1(2):e39. PubMed ID: 33524237 [TBL] [Abstract][Full Text] [Related]
48. Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts. Preskey D; Allison TF; Jones M; Mamchaoui K; Unger C Biochem Biophys Res Commun; 2016 May; 473(3):743-51. PubMed ID: 26449459 [TBL] [Abstract][Full Text] [Related]
50. Can controlled cellular reprogramming be achieved using microRNAs? Sun X; Fu X; Han W; Zhao Y; Liu H Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195 [TBL] [Abstract][Full Text] [Related]
51. Design of Tusup M; French LE; De Matos M; Gatfield D; Kundig T; Pascolo S Chimia (Aarau); 2019 May; 73(5):391-394. PubMed ID: 31118121 [TBL] [Abstract][Full Text] [Related]
52. Engineering kidney cells: reprogramming and directed differentiation to renal tissues. Kaminski MM; Tosic J; Pichler R; Arnold SJ; Lienkamp SS Cell Tissue Res; 2017 Jul; 369(1):185-197. PubMed ID: 28560692 [TBL] [Abstract][Full Text] [Related]
54. Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences. Rhoads RE Methods Mol Biol; 2016; 1428():3-27. PubMed ID: 27236789 [TBL] [Abstract][Full Text] [Related]
55. Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species. Lahm H; Doppler S; Dreßen M; Werner A; Adamczyk K; Schrambke D; Brade T; Laugwitz KL; Deutsch MA; Schiemann M; Lange R; Moretti A; Krane M Stem Cells; 2015 Feb; 33(2):392-402. PubMed ID: 25335772 [TBL] [Abstract][Full Text] [Related]
56. mRNA-Based Therapeutics in Cancer Treatment. Sun H; Zhang Y; Wang G; Yang W; Xu Y Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839944 [TBL] [Abstract][Full Text] [Related]
57. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA. Baiersdörfer M; Boros G; Muramatsu H; Mahiny A; Vlatkovic I; Sahin U; Karikó K Mol Ther Nucleic Acids; 2019 Apr; 15():26-35. PubMed ID: 30933724 [TBL] [Abstract][Full Text] [Related]
58. Optimizing the process of nucleofection for professional antigen presenting cells. Mullins CS; Wegner T; Klar E; Classen CF; Linnebacher M BMC Res Notes; 2015 Sep; 8():472. PubMed ID: 26404473 [TBL] [Abstract][Full Text] [Related]
59. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
60. Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders. Miliotou AN; Pappas IS; Spyroulias G; Vlachaki E; Tsiftsoglou AS; Vizirianakis IS; Papadopoulou LC Mol Ther Nucleic Acids; 2021 Dec; 26():694-710. PubMed ID: 34703653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]